← SynDRA
ECABET
SynDRA canonical compound SYN0030620 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | CCKBR | GAST | NOXO1 |
|---|
| Mechanism of action | gastrin inhibitor | urease inhibitor |
|---|
| Indication | dry eye syndrome |
|---|
| Disease area | ophthalmology |
|---|
All known targets
Mechanisms of action (all sources)
- gastrin inhibitor
- urease inhibitor
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- HRH2
- HTR1A
- HTR2A
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MLNR
- NPY1R
- NR1I2
- NR3C1
- OPRD1
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- HRH3
- HRH1
- ADORA2A
- HDAC6
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
- AVPR2
- BDKRB2
Drug classes
- Anti-Infective Agents
- Anti-Ulcer Agents
- Anticarcinogenic Agents
- Antineoplastic Agents
- Enzyme Inhibitors
- Gastrointestinal Agents
- Protease Inhibitors
- Protective Agents
Cross-references
Synonyms
- TA-2711
- ecabet sodium
- Ecabet sodium
- Gastrom (TN)
- Ecabetum
- 2K02669KWP
- DTXCID5026881
- RefChem:136197
- Ecabet [INN]
- Ecabet (INN)
- C20H28O5S
- NCGC00181160-01
- Ecabetum [INN-Latin]
- UNII-2K02669KWP
- MFCD11044526
- ECABET [WHO-DD]
- ECABET [MI]
- SCHEMBL373030
- orb1688413
- SCHEMBL29727401
- CHEBI:135593
- HY-B0691
- Tox21_112763
- AKOS015917316
- AS-55875
- DA-52792
- CAS-33159-27-2
- CS-0009589
- NS00069179
- D07885
- D81888
- T61623
- F320122
- BRD-K03353589-236-01-4
- エカベトナトリウム
- CS-0020410
- MLS006010228
- TA-2711E
Look up ECABET in the interactive SynDRA portal →